| dc.contributor.author | Elitok, Ali | |
| dc.contributor.author | Emet, Samim | |
| dc.contributor.author | Cimen, A. O. | |
| dc.date.accessioned | 2021-03-05T11:13:30Z | |
| dc.date.available | 2021-03-05T11:13:30Z | |
| dc.date.issued | 2019 | |
| dc.identifier.citation | Cimen A. O. , Emet S., Elitok A., "Endocan: a biomarker predicting successful reperfusion after coronary artery by-pass surgery of acute coronary syndrome patients.", European review for medical and pharmacological sciences, cilt.23, ss.338-342, 2019 | |
| dc.identifier.issn | 1128-3602 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_a71754f9-f563-46f2-a56f-bd3534765ed5 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/111715 | |
| dc.identifier.uri | https://doi.org/10.26355/eurrev_201901_16781 | |
| dc.description.abstract | OBJECTIVE: Endothelial specific molecule 1 (Endocan) is a biomarker of the inflammatory process occurring in endothelial cells. It was shown that endocan was increased in acute coronary syndromes. We aimed at investigating the endocan levels in acute coronary syndrome patients after coronary bypass surgery. | |
| dc.language.iso | eng | |
| dc.subject | Temel Eczacılık Bilimleri | |
| dc.subject | FARMAKOLOJİ VE ECZACILIK | |
| dc.subject | Farmakoloji ve Toksikoloji | |
| dc.subject | Yaşam Bilimleri (LIFE) | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Eczacılık | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Temel Bilimler | |
| dc.title | Endocan: a biomarker predicting successful reperfusion after coronary artery by-pass surgery of acute coronary syndrome patients. | |
| dc.type | Makale | |
| dc.relation.journal | European review for medical and pharmacological sciences | |
| dc.contributor.department | Bahçeşehir Üniversitesi , , | |
| dc.identifier.volume | 23 | |
| dc.identifier.issue | 1 | |
| dc.identifier.startpage | 338 | |
| dc.identifier.endpage | 342 | |
| dc.contributor.firstauthorID | 84767 | |
